[1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine

C13H22N4 — CID 103025995

IUPAC[1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine
SMILESCn1nccc1CCC(NN)C1C2CCCC21
InChIInChI=1S/C13H22N4/c1-17-9(7-8-15-17)5-6-12(16-14)13-10-3-2-4-11(10)13/h7-8,10-13,16H,2-6,14H2,1H3
InChIKeyNBHGBBRPCSWVMB-UHFFFAOYSA-N
MW234.35 g/mol
LogP1.23
Rot. Bonds5

About [1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine

[1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine (PubChem CID 103025995) has the molecular formula C13H22N4 and a molecular weight of 234.35 g/mol. Its IUPAC name is [1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine.

Molecular Properties

Compound Name[1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine
PubChem CID103025995
Molecular FormulaC13H22N4
Molecular Weight234.35 g/mol
Exact Mass234.18
IUPAC Name[1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine
SMILESCn1nccc1CCC(NN)C1C2CCCC21
InChIInChI=1S/C13H22N4/c1-17-9(7-8-15-17)5-6-12(16-14)13-10-3-2-4-11(10)13/h7-8,10-13,16H,2-6,14H2,1H3
InChIKeyNBHGBBRPCSWVMB-UHFFFAOYSA-N
XLogP1.23
TPSA55.87 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms17
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500234.35
LogP ≤ 51.23
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-((1-methyl-1H-pyrazol-5-yl)methyl)piperidine
CID 63961604
rac-(1R,2R)-2-(1-methyl-1H-pyrazol-5-yl)cyclopropan-1-amine dihydrochloride
CID 129841629
3-(5-cyclopropyl-1H-pyrazol-1-yl)propan-1-amine
CID 19619792
3-(1-methyl-1H-pyrazol-5-yl)cyclopentan-1-amine
CID 64504110
3-methyl-2-(1-methyl-1H-pyrazol-5-yl)butan-1-amine
CID 75355391
rac-methyl((((2R,3S)-1-methyl-2-(1-methyl-1H-pyrazol-5-yl)piperidin-3-yl)methyl))amine
CID 119031225
3-(5-cyclopropyl-1H-pyrazol-1-yl)propan-1-amine dihydrochloride
CID 137919903
cis-(1R,2S)-2-(2-methylpyrazol-3-yl)cyclohexan-1-amine
CID 178190376
[3-(2-Methylpyrazol-3-yl)-1-[3-(trifluoromethyl)cyclohexyl]propyl]hydrazine
CID 103025975
[3-(2-Methylpyrazol-3-yl)-1-[2-(trifluoromethyl)cyclohexyl]propyl]hydrazine
CID 103026021
[1,1,1-Trifluoro-5-(2-methylpyrazol-3-yl)pentan-3-yl]hydrazine
CID 103026083
[3-(2-Methylpyrazol-3-yl)-1-[4-(trifluoromethyl)cyclohexyl]propyl]hydrazine
CID 103026103

Frequently Asked Questions

What is the IUPAC name of [1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine?
The IUPAC name of [1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine (CID 103025995) is [1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine.
What is the SMILES notation for [1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine?
The canonical SMILES for [1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine is Cn1nccc1CCC(NN)C1C2CCCC21.
What is the InChIKey of [1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine?
The InChIKey is NBHGBBRPCSWVMB-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H22N4/c1-17-9(7-8-15-17)5-6-12(16-14)13-10-3-2-4-11(10)13/h7-8,10-13,16H,2-6,14H2,1H3.
What are the key properties of [1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine?
[1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine has a molecular weight of 234.35 g/mol, XLogP of 1.23, 5 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [1-(6-bicyclo[3.1.0]hexanyl)-3-(2-methylpyrazol-3-yl)propyl]hydrazine is sourced from PubChem (CID 103025995), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).